» Articles » PMID: 27654305

Antioxidant Response of Chronic Wounds to Hyperbaric Oxygen Therapy

Overview
Journal PLoS One
Date 2016 Sep 23
PMID 27654305
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the effects of the clinical hyperbaric oxygen therapy (HBOT) on the plasma antioxidant response and levels of endothelin-1, Interleukine-6 (IL-6) and vascular endothelial growth factor (VEGF) in patients with chronic wounds (20.2±10.0 months without healing). They received 20 HBOT sessions (five sessions/week), and blood samples were obtained at sessions 1, 5 and 20 before and 2 hours after the HBOT. An additional blood sample was collected 1 month after wound recovery. Serum creatine kinase activity decreased progressively in accordance with the wound healing. Plasma catalase activity significantly increased after the first and fifth sessions of HBOT. Plasma myeloperoxidase activity reported significantly lower values after sessions. Plasma VEGF and IL-6 increased after sessions. Endothelin-1 levels were progressively decreasing during the HBOT, being significant at the session 20. Plasma malondialdehyde concentration was significantly reduced at the last session. Both creatine kinase activity and malondialdehyde levels were maintained lower 1 month after wound recovery respect to initial values. In conclusion, HBOT enhanced the plasma antioxidant defenses and may contribute to activate the healing resolution, angiogenesis and vascular tone regulation by increasing the VEGF and IL-6 release and the endothelin-1 decrease, which may be significant factors in stimulating wound healing.

Citing Articles

Hyperbaric Oxygen Therapy for the Treatment of Bone-Related Diseases.

Feng J, Zhu C, Zou J, Zhang L Int J Mol Sci. 2025; 26(3).

PMID: 39940834 PMC: 11817436. DOI: 10.3390/ijms26031067.


Hyperbaric Oxygen Therapy Improved Neovascularisation Following Limb Ischaemia-The Role of ROS Mitigation.

Lin Y, Shih J, Lin Y, Niu K, Hong C, Chen Z J Cell Mol Med. 2024; 28(24):e70310.

PMID: 39720917 PMC: 11669187. DOI: 10.1111/jcmm.70310.


Hyperbaric Oxygen Therapy Ameliorates Olanzapine-Induced Hypolocomotion in a Rat Model.

Altarifi A, Arab L, Al-Azaizeh R, Khataybeh B, Al-Ghadi M, Khalifeh M Life (Basel). 2024; 14(11).

PMID: 39598279 PMC: 11595574. DOI: 10.3390/life14111482.


Is there a rationale for hyperbaric oxygen therapy in the patients with Post COVID syndrome? : A critical review.

Pawlik M, Rinneberg G, Koch A, Meyringer H, Loew T, Kjellberg A Eur Arch Psychiatry Clin Neurosci. 2024; 274(8):1797-1817.

PMID: 39545965 PMC: 11579208. DOI: 10.1007/s00406-024-01911-y.


Hyperbaric Oxygen Therapy Reduces Oxidative Stress and Inflammation, and Increases Growth Factors Favouring the Healing Process of Diabetic Wounds.

Capo X, Monserrat-Mesquida M, Quetglas-Llabres M, Batle J, Tur J, Pons A Int J Mol Sci. 2023; 24(8).

PMID: 37108205 PMC: 10139175. DOI: 10.3390/ijms24087040.


References
1.
Lundberg J, Weitzberg E, Gladwin M . The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008; 7(2):156-67. DOI: 10.1038/nrd2466. View

2.
Chen Q, Banick P, Thom S . Functional inhibition of rat polymorphonuclear leukocyte B2 integrins by hyperbaric oxygen is associated with impaired cGMP synthesis. J Pharmacol Exp Ther. 1996; 276(3):929-33. View

3.
Sheffield P . Measuring tissue oxygen tension: a review. Undersea Hyperb Med. 1998; 25(3):179-88. View

4.
Garcia-Covarrubias L, Sanchez-Rodriguez E . [Hyperbaric oxygenation therapy, basic concepts]. Gac Med Mex. 2000; 136(1):45-56. View

5.
Zhang Q, Chang Q, Cox R, Gong X, Gould L . Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol. 2008; 128(8):2102-12. DOI: 10.1038/jid.2008.53. View